If you are thinking about an exosome injection for joint pain, read this first. The FDA says there are currently no FDA-approved exosome products.1 Texas Orthobiologics does not offer them. We use PRP and BMAC (stem cells), which are made from your own blood or bone marrow.
This page explains what exosomes are, what the FDA has said, what the research shows, and how exosomes compare with PRP and BMAC (stem cells). It is written by a board-certified orthopedic surgeon who has worked in this field since 2006.
Want to talk it through? Call (877) 777-8883 to book a consult, or request an appointment.
The three options side by side
| Exosomes | PRP | BMAC (stem cells) | |
|---|---|---|---|
| Where it comes from | A donor: usually umbilical cord, placenta or amniotic tissue, processed in a lab | Your own blood | Your own bone marrow |
| When it is made | Ahead of time, then shipped and stored | In the office, the same day | In the office, the same day |
| FDA status | No FDA-approved exosome products1 | Made from your own body. Not considered a biologic drug when used according to current FDA regulations. | |
| Human research for joints | Very little; see below | The most studied of the three | Studied for knee arthritis with long follow-up |
| Offered at Texas Orthobiologics | No | Yes | Yes |
| Starting investment | Not offered | $1,500 | $5,000 |
What exosomes are
Exosomes are tiny packets that cells release to send signals to other cells. Every cell in your body makes them. In the lab they are interesting, and researchers are studying whether they could be used as medicine one day.
The exosome products sold for injection today are different from the ones your own body makes. They are collected from donated tissue, most often umbilical cord, placenta or amniotic fluid, then processed, bottled and shipped. A product that comes from another person is called an allograft.
What the FDA has said
- No approved products. The FDA's consumer alert states: "There are currently no FDA-approved exosome products." It also says exosome products meant to treat diseases or conditions in people generally require FDA approval.1
- A safety notice. In December 2019 the FDA issued a public safety notification after patients in Nebraska had serious problems following treatment with unapproved products marketed as containing exosomes.2
- Other donor products too. The same FDA alert lists umbilical cord blood, Wharton's jelly and amniotic fluid products as widely promoted, and says none are approved for orthopedic conditions.1
- The FDA invites questions. Anyone can call the FDA at 800-835-4709 to ask whether a product is approved or how it is regulated.1
Donor products carry a risk that your own tissue does not: contamination during processing. In a national investigation, 20 patients developed bacterial infections after receiving umbilical cord blood products marketed as stem cell treatment. All but one needed to be hospitalized, and 65% of the unopened vials that were tested were contaminated.3
What the research shows
Most of what is written about exosomes comes from lab dishes and animals. Human research for joints is just starting.
- A randomized, placebo-controlled trial. Thirty-one patients with arthritis in both knees had donor-derived exosome-type particles injected into one knee and salt water into the other. At two and six months there was no difference in pain, function or MRI. The injection was safe, but it did no better than placebo.4
- An early safety study. A small dose-finding study of umbilical cord exosomes for knee arthritis reported no harmful effects and some improvement compared with before treatment. It was designed to test safety, not to prove the treatment works.5
What this means. Exosomes may turn out to be useful someday. Today there is no approved product and no solid proof that they help a painful joint.
Why Dr. Buford does not offer exosomes or other donor products
"I have never offered any allograft injectable product. That includes exosomes, Wharton's jelly, amniotic, cord blood and placental products, and regenerative protein array (RPA). In my opinion, these are all allograft products that have significant regulatory requirements, and potential complications, before being used in humans."
Don Buford, MD
Hear it from him in this short video.
What we use instead: your own tissue
PRP
PRP stands for platelet-rich plasma. Blood is drawn from your arm, the platelets are concentrated in the office, and the PRP is placed where it is needed under ultrasound guidance the same day. Of the three options on this page, PRP has been studied the most.
All PRP is not the same. We calculate the platelet dose for every procedure and record it in our registry. More than 90% of our procedures need only one injection (Texas Orthobiologics registry data, 2022 to 2026).
BMAC (stem cells)
BMAC stands for bone marrow aspirate concentrate. A small amount of bone marrow is drawn from the back of your pelvis, concentrated in the office and placed the same day. Nothing comes from a donor. BMAC (stem cells) is a bigger procedure and a larger investment than PRP, and it is usually discussed for more advanced problems.
The critical difference. PRP and BMAC (stem cells) come from your own body and are prepared and used in a single visit. When they are used according to current FDA regulations, neither one is considered a biologic drug. That is unlike the donor products described on this page. The FDA regulates exosome, umbilical cord and amniotic products sold for joint injections as drugs and biologics that need FDA approval, and none has it.1
At your consult Dr. Buford will explain how each of our treatments is regulated and what the research shows for your problem.
Treatment guides
- PRP injection for knee arthritis
- BMAC (stem cell) therapy for knee arthritis
- PRP and BMAC (stem cell) therapy for meniscus tears
- PRP injection for shoulder pain and rotator cuff tears
- BMAC (stem cell) therapy for rotator cuff tears
- PRP and BMAC (stem cell) therapy for hip arthritis
- PRP and BMAC (stem cell) therapy for tennis elbow and golfer's elbow
- Back pain and herniated discs: options to try first
- Frozen shoulder treatment
- PRP and BMAC (stem cell) investment
Questions to ask any clinic
- Does this product come from my own body or from a donor?
- If it comes from a donor, is it FDA approved for my condition?
- If it is not approved, is it being given as part of an FDA-cleared study?
- What dose will I receive, and is it measured?
- Who is doing the injection, and is it guided by ultrasound?
We will answer every one of these about our own treatments.
Common questions
Are exosomes FDA approved?
No. The FDA states that there are currently no FDA-approved exosome products. The FDA also says that exosome products meant to treat diseases or conditions in people generally require FDA approval.
Does Texas Orthobiologics offer exosome injections?
No. Dr. Buford has never offered any injectable product that comes from a donor. That includes exosomes, Wharton's jelly, amniotic, cord blood and placental products, and regenerative protein array (RPA). He uses PRP and BMAC (stem cells), which are made from your own blood or bone marrow the same day.
What is the difference between exosomes and PRP?
Exosome products sold for injection are made in a lab from donated tissue, such as umbilical cord or placenta. PRP is made from your own blood in the office and used the same day. PRP has been tested in many randomized trials for joint and tendon problems. Exosomes have very little human research so far.
Do exosomes work better than stem cells for joints?
There is no good evidence of that. In a randomized, placebo-controlled trial of knee arthritis, an injection of donor-derived exosome-type particles was safe but did no better than salt water. BMAC (stem cells) from your own bone marrow has been followed for many years in knee arthritis studies.
What is a regenerative protein array (RPA)?
It is a donor-derived product sold for injection. Dr. Buford does not offer it. In his opinion it belongs with the other donor products that have significant regulatory requirements before being used in people.
What should I ask a clinic before any regenerative injection?
Ask where the product comes from: your own body or a donor. If it comes from a donor, ask whether it is FDA approved for your condition, and if not, whether it is being given as part of an FDA-cleared study. Ask what dose you will receive and whether it is measured.
How do I find out which option is right for me?
Call the office at (877) 777-8883 and book a consult. Dr. Buford will examine the joint, look at it with ultrasound, review your imaging and tell you whether PRP, BMAC (stem cells), surgery or something else makes sense.
Book a consult
If you have been looking at exosomes for a painful knee, shoulder, hip or elbow, the next step is a visit. Dr. Buford will examine the joint, look at it with ultrasound, review your imaging and tell you plainly what he would do.
Call (877) 777-8883 or request an appointment. Office visits in Dallas and telemedicine calls are available.
This page is general education, not medical or legal advice. FDA information was checked on November 16, 2026 and can change. Results vary.
References
- US Food and Drug Administration. Consumer alert on regenerative medicine products including stem cells and exosomes. Published July 22, 2020. Content current as of April 9, 2024. Accessed November 16, 2026. fda.gov
- US Food and Drug Administration. Public safety notification on exosome products. Published December 2019. Accessed November 16, 2026. fda.gov
- Hartnett KP, Powell KM, Rankin D, et al. Investigation of bacterial infections among patients treated with umbilical cord blood-derived products marketed as stem cell therapies. JAMA Netw Open. 2021;4(10):e2128615. doi:10.1001/jamanetworkopen.2021.28615
- Bolandnazar NS, Raeissadat SA, Haghighatkhah H, et al. Safety and efficacy of placental mesenchymal stromal cells-derived extracellular vesicles in knee osteoarthritis: a randomized, triple-blind, placebo-controlled clinical trial. BMC Musculoskelet Disord. 2024;25(1):856. doi:10.1186/s12891-024-07979-w
- Wang Y, Kong Y, Du J, et al. Injection of human umbilical cord mesenchymal stem cells exosomes for the treatment of knee osteoarthritis: from preclinical to clinical research. J Transl Med. 2025;23(1):641. doi:10.1186/s12967-025-06623-y
